BINEX Co., Ltd. (053030.KQ)
KRW 17490.0
(-3.95%)
KRW 17490.0
(-3.95%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 10.87 Billion KRW | -60.91% |
| 2022 | 25.59 Billion KRW | 36.87% |
| 2021 | 30.93 Billion KRW | -14.67% |
| 2020 | 13.19 Billion KRW | 7.28% |
| 2019 | 21.72 Billion KRW | 28.45% |
| 2018 | 15.82 Billion KRW | 1272.8% |
| 2017 | -835.53 Million KRW | -81.08% |
| 2016 | 6.21 Billion KRW | -51.88% |
| 2015 | 5.16 Billion KRW | 0.0% |
| 2013 | 1.6 Billion KRW | -107.3% |
| 2012 | 4.07 Billion KRW | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -7.62 Billion KRW | -718.67% |
| 2024 Q2 | -5.26 Billion KRW | 38.39% |
| 2023 Q1 | 10.39 Billion KRW | 211.91% |
| 2023 Q2 | 2.7 Billion KRW | -73.96% |
| 2023 FY | - KRW | -60.91% |
| 2023 Q3 | -2.36 Billion KRW | -187.48% |
| 2023 Q4 | -933.07 Million KRW | 60.58% |
| 2022 Q4 | 3.33 Billion KRW | -58.85% |
| 2022 Q3 | 8.09 Billion KRW | -18.46% |
| 2022 Q2 | 9.92 Billion KRW | 132.23% |
| 2022 FY | - KRW | 36.87% |
| 2022 Q1 | 4.27 Billion KRW | -41.02% |
| 2021 Q1 | 5.5 Billion KRW | -0.19% |
| 2021 Q2 | 874.34 Million KRW | -84.11% |
| 2021 Q3 | 4.99 Billion KRW | 470.89% |
| 2021 Q4 | 7.24 Billion KRW | 45.23% |
| 2021 FY | - KRW | -14.67% |
| 2020 Q2 | 6.68 Billion KRW | 117.25% |
| 2020 Q3 | 6.54 Billion KRW | -2.18% |
| 2020 Q4 | 5.51 Billion KRW | -15.73% |
| 2020 FY | - KRW | 7.28% |
| 2020 Q1 | 3.07 Billion KRW | -45.42% |
| 2019 Q4 | 5.63 Billion KRW | 15.66% |
| 2019 Q2 | 6 Billion KRW | 57.06% |
| 2019 Q1 | 3.82 Billion KRW | -53.74% |
| 2019 FY | - KRW | 28.45% |
| 2019 Q3 | 4.87 Billion KRW | -18.74% |
| 2018 Q2 | 1.41 Billion KRW | 10.49% |
| 2018 FY | - KRW | 1272.8% |
| 2018 Q4 | 8.25 Billion KRW | 69.3% |
| 2018 Q3 | 4.87 Billion KRW | 244.92% |
| 2018 Q1 | 1.28 Billion KRW | 653.11% |
| 2017 FY | - KRW | -81.08% |
| 2017 Q3 | -225.83 Million KRW | 75.67% |
| 2017 Q2 | -928.23 Million KRW | -136.56% |
| 2017 Q4 | -231.44 Million KRW | -2.49% |
| 2017 Q1 | 2.53 Billion KRW | 1093.49% |
| 2016 Q2 | 2.31 Billion KRW | 0.03% |
| 2016 Q3 | 1.71 Billion KRW | -25.86% |
| 2016 Q4 | -255.54 Million KRW | -114.86% |
| 2016 FY | - KRW | -51.88% |
| 2016 Q1 | 2.31 Billion KRW | 111.65% |
| 2015 Q1 | 2.07 Billion KRW | 0.0% |
| 2015 Q4 | 1.09 Billion KRW | -71.7% |
| 2015 FY | - KRW | 0.0% |
| 2015 Q3 | 3.87 Billion KRW | 63.23% |
| 2015 Q2 | 2.37 Billion KRW | 14.38% |
| 2014 Q1 | 1.89 Billion KRW | 165.77% |
| 2014 Q2 | 2.96 Billion KRW | 56.94% |
| 2014 Q3 | 1.86 Billion KRW | -37.06% |
| 2013 Q4 | -2.87 Billion KRW | -284.41% |
| 2013 Q1 | -653.37 Million KRW | -129.93% |
| 2013 Q3 | 1.55 Billion KRW | -6.76% |
| 2013 Q2 | 1.67 Billion KRW | 355.82% |
| 2013 FY | - KRW | -107.3% |
| 2012 Q3 | -351.38 Million KRW | 0.0% |
| 2012 Q4 | 2.18 Billion KRW | 721.2% |
| 2012 FY | - KRW | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| HLB Co., Ltd. | -172.27 Billion KRW | 106.311% |
| iNtRON Biotechnology, Inc. | -6.23 Billion KRW | 274.381% |
| Bioneer Corporation | 10.04 Billion KRW | -8.253% |
| Anterogen.Co.,Ltd. | -437.82 Million KRW | 2583.197% |
| MEDIPOST Co., Ltd. | -19.39 Billion KRW | 156.066% |
| CrystalGenomics, Inc. | -42.79 Billion KRW | 125.404% |
| Helixmith Co., Ltd | -53 Billion KRW | 120.512% |
| Chabiotech Co.,Ltd. | 70.08 Billion KRW | 84.488% |
| Medy-Tox Inc. | 32.69 Billion KRW | 66.75% |
| Peptron, Inc. | -12.65 Billion KRW | 185.942% |
| Amicogen, Inc. | 13.95 Billion KRW | 22.082% |
| Genexine, Inc. | -40.87 Billion KRW | 126.596% |
| HLB Therapeutics Co.,Ltd. | 8.22 Billion KRW | -32.109% |
| LegoChem Biosciences, Inc. | -71.38 Billion KRW | 115.23% |
| ALTEOGEN Inc. | 440.04 Million KRW | -2370.684% |
| PharmaResearch Co., Ltd. | 104.25 Billion KRW | 89.572% |
| SillaJen, Inc. | -17.35 Billion KRW | 162.654% |
| JETEMA, Co., Ltd. | 11 Billion KRW | 1.233% |
| OliX Pharmaceuticals,Inc | -11.13 Billion KRW | 197.638% |
| Genomictree Inc. | -6.33 Billion KRW | 271.704% |
| MedPacto, Inc. | -32.6 Billion KRW | 133.341% |
| D&D Pharmatech | -9.05 Billion KRW | 220.028% |
| EASY BIO,Inc. | 24.32 Billion KRW | 55.302% |
| GI Innovation, Inc. | -51.33 Billion KRW | 121.18% |